Source: The Business Journals: St. Louis

Euclises: Talley hopes Euclises could be the next Celebrex

John Talley, chief scientific officer of Euclises Pharmaceuticals, is arguably one of the most accomplished medicinal chemists in the world. For the second year in a row The Medicine Maker, a global magazine focused on the development and manufacturing of drugs and biologics, has placed him on their Power List of the top 100 most influential people in the world of medical advancement. Talley ranked number 17 on this year's list. Talley is the inventor of eight drugs that have achieved market...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Bobby W. Sandage's photo - President & CEO of Euclises

President & CEO

Bobby W. Sandage

CEO Approval Rating

79/100

Read more